Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein

Molecular Microbiology

Volumn 54, Issue 3, 2004, Pages 665-675

  Dean, Paul ^a   Kenny, Brendan ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL SURFACE PROTEIN; INTIMIN; MEMBRANE PROTEIN; MITOCHONDRIA ASSOCIATED PROTEIN; OUTER MEMBRANE PROTEIN; PROTEIN ESPF; PROTEIN TIR; RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIARRHEA; ESCHERICHIA COLI; HOST CELL; HUMAN; HUMAN CELL; INTESTINE FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TIGHT JUNCTION;

ADHESINS, BACTERIAL; CACO-2 CELLS; CELL FRACTIONATION; CELL MEMBRANE; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; HUMANS; INTESTINAL MUCOSA; MEMBRANE PROTEINS; MITOCHONDRIA; PSEUDOPODIA; SIGNAL TRANSDUCTION; TIGHT JUNCTIONS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA;

EID: 7644225138     PISSN: 0950382X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2958.2004.04308.x     Document Type: Article

References (35)

1. Balkovetz, D.F., and Katz, J. (2003) Bacterial invasion by a paracellular route: divide and conquer. Microbes Infect 5: 613-619.
2. Canil, C., Rosenshine, I., Ruschkowski, S., Donnenberg, M.S., Kaper, J.B., and Finlay, B.B. (1993) Enteropathogenic Escherichia coli decreases the transepithelial electrical resistance of polarized epithelial monolayers. Infect Immun 61: 2755-2762.
3. Clarke, S.C., Haigh, R.D., Freestone, P.P.E., and Williams, P.M. (2003) Virulence of enteropathogenic Escherichia coli, a global pathogen. Clin Microbiol Rev 16: 365-378.
4. Collington, G.K., Booth, I.W., Donnenberg, M.S., Kaper, J.B., and Knutton, S. (1998) Enteropathogenic Escherichia coli virulence genes encoding secreted signalling proteins are essential for modulation of Caco-2 cell electrolyte transport. Infect Immun 66: 6049-6053.
5. Donnenberg, M.S., and Kaper, J.B. (1991) Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive selection suicide vector. Infect Immun 59: 4310-4317.
6. Donnenberg, M.S., Calderwood, S.B., Donohuerolfe, A., Keusch, G.T., and Kaper, J.B. (1990) Construction and analysis of TnphoA mutants of enteropathogenic Escherichia coli unable to invade HEp-2 cells. Infect Immun 58: 1561-1571.
7. Elliott, S.J., Krejany, E.O., Mellies, J.L., Robins-Browne, R.M., Sasakawa, C., and Kaper, J.B. (2001) EspG, a novel type III system-secreted protein from enteropathogenic Escherichia coli with similarities to VirA of Shigella flexneri. Infect Immun 69: 4027-4033.
8. Frankel, G., Lider, O., Hershkoviz, R., Mould, A.P., Kachalsky, S.G., Candy, D.C.A., et al. (1996) The cell binding domain of intimin from enteropathogenic Escherichia coli binds to beta(1) integrins. J Biol Chem 271: 20359-20364.
9. Gopalakrishnan, S., Dunn, K.W., and Marrs, J.A. (2002) Rac1, but not RhoA, signaling protects epithelial adherens junction assembly during ATP depletion. Am J Physiol Cell Physiol 283: C261-C272.
10. Higgins, L.M., Frankel, G., Connerton, I., Goncalves, N.S., Dougan, G., and MacDonald, T.T. (1999) Role of bacterial intimin in colonic hyperplasia and inflammation. Science 285: 588-591.
11. Jepson, M.A., Pellegrin, S., Peto, L., Banbury, D.N., Leard, A.D., Mellor, H., and Kenny, B. (2003) Synergistic roles for the Map and Tir effector molecules in mediating uptake of enteropathogenic Escherichia coli (EPEC) into non-phagocytic cells. Cell Microbiol 5: 773-783.
12. Kenny, B. (2002) Enteropathogenic Escherichia coli (EPEC) - a crafty subversive little bug. Microbiology 148: 1967-1978.
13. Kenny, B., and Jepson, M. (2000) Targeting of an enteropathogenic Escherichia coli (EPEC) effector protein to host mitochondria. Cell Microbiol 2: 579-590.
14. Kenny, B., DeVinney, R., Stein, M., Reinscheid, D.J., Frey, E.A., and Finlay, B.B. (1997) Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91: 511-520.
15. Kenny, B., Ellis, S., Leard, A.D., Warawa, J., Mellor, H., and Jepson, M.A. (2002) Co-ordinate regulation of distinct host cell signalling pathways by multifunctional enteropathogenic Escherichia coli effector molecules. Mol Microbiol 44: 1095-1107.
16. Laemmlli, U. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
17. Lapierre, L.A. (2000) The molecular structure of the tight junction. Adv Drug Deliv Rev 41: 255-264.
18. Levine, M.M., Nataro, J.P., Karch, H., Baldini, M.M., Kaper, J.B., and Black, K.L. (1985) The diarrheal response of humans to some classical serotypes of enteropathogenic Escherichia coli is dependent on a plasmid encoding an enteroadhesiveness factor. J Infect Dis 152: 550-559.
19. McNamara, B.P., and Donnenberg, M.S. (1998) A novel proline-rich protein, EspF, is secreted from enteropathogenic Escherichia coli via the type III export pathway. FEMS Microbiol Lett 166: 71-78.
20. McNamara, B.P., Koutsouris, A., O'Connell, C.B., Nougayrede, J.P., Donnenberg, M.S., and Hecht, G. (2001) Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function. J Clin Invest 107: 621-629.
21. Madsen, K.L., Yanchar, N.L., Sigalet, D.L., Reigel, T., and Fedorak, R.N. (1995) FK506 increases permeability in rat intestine by inhibiting mitochondrial function. Gastroenterology 109: 107-114.
22. Mandel, L.J., Bacallo, R., and Zampighi, G. (1993) Uncoupling of the molecular fence and paracellular gate functions in epithelial tight junctions. Nature 361: 552-555.
23. Muza-Moons, M.M., Koutsouris, A., and Hecht, G. (2003) Disruption of cell polarity by enteropathogenic Escherichia coli enables basolateral membrane proteins to migrate apically and to potentiate physiological consequences. Infect Immun 71: 7069-7078.
24. Nataro, J.P., and Kaper, J.B. (1998) Diarrheagenic Escherichia coli. Clin Microbiol Rev 11: 142-201.
25. Phillips, A.D., Giron, J., Hicks, S., Dougan, G., and Frankel, G. (2000) Intimin from enteropathogenic Escherichia coli mediates remodelling of the eukaryotic cell surface. Microbiology 146: 1333-1344.
26. Philpott, D.J., McKay, D.M., Sherman, P.M., and Perdue, M.H. (1996) Infection of T84 cells with enteropathogenic Escherichia coli alters barrier and transport functions. Am J Physiol 33: G634-G645.
27. Savkovic, S.D., Ramaswamy, A., Koutsouris, A., and Hecht, G. (2001) EPEC-activated ERK1/2 participate in inflammatory response but not tight junction barrier disruption. Am J Physiol 281: G890-G898.
28. Simonovic, I., Rosenberg, J., Koutsouris, A., and Hecht, G. (2000) Enteropathogenic Escherichia coli dephosphorylates and dissociates occludin from intestinal epithelial tight junctions. Cell Microbiol 2: 305-315.
29. Sinclair, J.F., and O'Brien, A.D. (2002) Cell surface-localized nucleolin is a eukaryotic receptor for the adhesin intimin-gamma of enterohemorrhagic Escherichia coli O157:H7. J Biol Chem 277: 2876-2885.
30. Spitz, J., Yuhan, R., Koutsouris, A., Blatt, C., Alverdy, J., and Hecht, G. (1995) Enteropathogenic Escherichia coli adherence to intestinal epithelial monolayers diminishes barrier function. Am J Physyol 31: G374-G379.
31. Tu, X.L., Nisan, I., Yona, C., Hanski, E., and Rosenshine, I. (2003) EspH, a new cytoskeleton-modulating effector of enterohaemorrhagic and enteropathogenic Escherichia coli. Mol Microbiol 47: 595-606.
32. Warawa, J., Finlay, B.B., and Kenny, B. (1999) Type III secretion-dependent hemolytic activity of enteropathogenic Escherichia coli. Infect Immun 67: 5538-5540.
33. Yuhan, R., Koutsouris, A., and Hecht, G. (1995) Enteropathogenic E. coli induced phosphorylation of myosin light chain increases intestinal epithelial paracellular permeability. Gastroenterology 108: A948-A948.
34. Zhou, D.G. (2001) Collective efforts to modulate the host actin cytoskeleton by Salmonella type III-secreted effector proteins. Trends Microbiol 9: 567-569.
35. Zolotarevsky, Y., Hecht, G., Koutsouris, A., Gonzalez, D.E., Quan, C., Tom, J., et al. (2002) A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease. Gastroenterology 123: 163-172.